- Mylan launches generic version of Trilipix
- New cholesterol, obesity guidelines give greater role to statins, call for more research into weight-loss drugs
- Teva, Mylan launch Viagra generics in Europe
- Walgreens expands preventive healthcare services to Maryland market
- Reports: Financial analysts say new cholesterol guidelines could mean lower use of still-experimental cholesterol-lowering biologics
PITTSBURGH — Mylan has begun shipping a generic drug for cholesterol, the company said Monday.
Mylan said a subsidiary had started shipping fenofibrate capsules in the 43-mg and 130-mg strengths. The drug is a generic version of Lupin Atlantis Holdings Antara, used in combination with diet to reduce elevated bad cholesterol and other blood lipids and increase beneficial HDL cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia.
Various versions of the drug had sales of about $60 million during the 12-month period that ended in September 2012, according to IMS Health.